Woolley J
Department of Psychiatry and Behavioral Sciences. & Weil Institute for Neurosciences, University of California San Francisco, California San Francisco Veterans Affairs Health Care System, San Francisco, USA; San Francisco Veterans Affairs Medical Center, San Francisco, CA, USA; Translational Psychedelic Research Program (TrPR), Department of Psychiatry and Behavioral Sciences, Weill Institute for Neurosciences, University of California, San Francisco, USA.
ArticlePsychedelics
Are psychedelics anti-inflammatory? A systematic review and meta-analysis of studies examining the immunomodulatory effects of serotonergic psychedelics.
PreprintPsychedelics
TripTally: An Open-Access Calculator of Labor Costs Across Psychedelic Therapy Delivery Models
PreprintMDMA
MDMA-assisted Acceptance and Commitment Therapy for Posttraumatic Stress Disorder: Rationale for a New Approach
ArticleMDMA
Too big to fail? Comparing effect sizes of MDMA assisted therapy to unmasking bias.
ArticleMDMA
Modifying Informed Consent to Help Address Functional Unmasking in Psychedelic Clinical Trials.
ArticlePsilocybin
A systematic review of participant diversity in psychedelic-assisted psychotherapy trials.
ArticlePsilocybin
A Plea for Nuance: Should People with a Family History of Bipolar Disorder Be Excluded from Clinical Trials of Psilocybin Therapy?
ArticlePsilocybin
Psilocybin therapy and anorexia nervosa: a narrative review of safety considerations for researchers and clinicians.
ArticlePsilocybin
Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial.
ArticlePsilocybin
"But the reality is it's happening": A qualitative study of eating disorder providers about psilocybin-assisted psychotherapy.
PreprintAyahuasca
Effects of ayahuasca on gratitude and relationships with nature: An open-label, naturalistic study
PreprintAyahuasca
Increases in aesthetic experience following ayahuasca use: An open-label, naturalistic study
ArticlePsilocybin
"A sense of the bigger picture:" A qualitative analysis of follow-up interviews with people with bipolar disorder who self-reported psilocybin use.
ArticlePsilocybin
Risks and benefits of psilocybin use in people with bipolar disorder: An international web-based survey on experiences of 'magic mushroom' consumption.
ArticlePsilocybin